Andrew Catchpole
Chief Tech/Sci/R&D Officer at HVIVO PLC
Profile
Dr. Andrew Catchpole is a Chief Scientific Officer at hVIVO Ltd.
and a Chief Scientific Officer at hVIVO PLC.
Dr. Catchpole was previously employed as an Associate Director-Virology by Retroscreen Virology Ltd.
He received his undergraduate degree from the University of Warwick and a doctorate degree from the University of Oxford.
Andrew Catchpole active positions
| Companies | Position | Start |
|---|---|---|
| HVIVO PLC | Chief Tech/Sci/R&D Officer | 31/05/2020 |
| HVIVO PLC | Chief Tech/Sci/R&D Officer | 31/05/2020 |
Former positions of Andrew Catchpole
| Companies | Position | End |
|---|---|---|
hVIVO Services Ltd.
 hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Corporate Officer/Principal | 31/08/2014 |
Training of Andrew Catchpole
| University of Oxford | Doctorate Degree |
| University of Warwick | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HVIVO PLC | Commercial Services |
| Private companies | 2 |
|---|---|
hVIVO Services Ltd.
hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Technology Services |
hVIVO Ltd.
 hVIVO Ltd. Miscellaneous Commercial ServicesCommercial Services hVIVO Ltd. engages in the provision of clinical development services with a focus on human disease models. It specializes in human challenge studies using influenza, human rhinovirus, and respiratory syncytial virus for pharmaceutical and biotech companies. The company was founded by John Sidney Oxford in 1989 and is headquartered in London, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Andrew Catchpole
